Skip to content
healthcare.dev

Teriparatide

NDC 0093-1106, Teriparatide, injection, solution, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-1106
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208569
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERIPARATIDE ACETATE250 ug/mL

Pharmacologic classes

Parathyroid Hormone Analog [EPC]; Parathyroid Hormone [CS]

Package NDCNDC-11Package
0093-1106-16000931106161 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d371f0f7-d492-4481-b360-051456d56d65
  • NADAC price for package 00093110616

    GET /v1/drugs/nadac/00093110616

Use it

Look up 0093-1106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-1106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.